|
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
|
Feb 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Clonal dynamics of aplastic anemia/paroxysmal nocturnal hemoglobinuria
|
Dec 2019
|
Leukemia & Lymphoma
|
aplastic anemia
|
|
Clonal Hematopoiesis and therapy related MDS/AML
|
Mar 2019
|
Best Practice & Research. Clinical Heamatology
|
myelodysplastic syndromes (MDS)
|
|
Clonal hematopoiesis in acquired aplastic anemia
|
Apr 2016
|
Blood
|
aplastic anemia
|
|
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
|
Apr 2015
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Clonal selection in therapy related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment
|
Jan 2020
|
European Journal of Haematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Clustering of comorbidities is related to age and sex and impacts clinical outcome in myelodysplastic syndromes
|
Mar 2014
|
J Geriatr Oncol
|
myelodysplastic syndromes (MDS)
|
|
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?
|
May 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.
|
Aug 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Combination strategies in myelodysplastic syndromes.
|
Jan 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
